Cargando…
Therapeutic Potential of Selectively Targeting the α(2C)-Adrenoceptor in Cognition, Depression, and Schizophrenia—New Developments and Future Perspective
α(2A)- and α(2C)-adrenoceptors (ARs) are the primary α(2)-AR subtypes involved in central nervous system (CNS) function. These receptors are implicated in the pathophysiology of psychiatric illness, particularly those associated with affective, psychotic, and cognitive symptoms. Indeed, non-selectiv...
Autores principales: | Uys, Madeleine Monique, Shahid, Mohammed, Harvey, Brian Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558054/ https://www.ncbi.nlm.nih.gov/pubmed/28855875 http://dx.doi.org/10.3389/fpsyt.2017.00144 |
Ejemplares similares
-
Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective
por: Li, Yang, et al.
Publicado: (2021) -
Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats via α2A-Adrenoceptors
por: Kurzina, Natalia, et al.
Publicado: (2022) -
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
por: MacKay, Mary-Anne B., et al.
Publicado: (2019) -
Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018) -
Treating Depression With Tai Chi: State of the Art and Future Perspectives
por: Kong, Jian, et al.
Publicado: (2019)